Senior insider sale
Chief Business Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$136.8K
8.21K shares
What this filing means
KREMPA DAVID plans to sell 8.21K shares of ETON PHARMACEUTICALS, INC. valued at approximately $136.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2026ACC: 0001974078-26-000015
Officer· Chief Business Officer
Since Mar 2023
8.21K
Shares to sell
$136.8K
Approx. market value
6.47K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Grant
Cash
1/13/2026
6.47KTotal acquired6.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2026 | Grant Cash | 6.47K | — |
| Total | 6.47K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.26K
Market value
$106.5K
12/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.94K
Market value
$30.3K
1/14/2026
Total
Units
8.21K
Value
$136.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/12/2025 | 6.26K | $106.5K | — | Completed |
| Planned — Approximate Date | ||||
1/14/2026 | 1.94K | $30.3K | NASDAQ | Planned |
| Total | 8.21K | $136.8K | ||